What is Kura Oncology's cost of product sales?

Kura Oncology (KURA) reported cost of product sales of $14.25K in Q4 2025.

What does cost of product sales mean?

This metric represents the direct costs attributable to the production and delivery of goods sold by the company during the reporting period. It encompasses raw materials, direct labor, and manufacturing overheads required to bring products to a saleable state. For a clinical-stage biopharmaceutical company, this figure reflects the scalability and efficiency of commercialized product manufacturing.

Kura Oncology KURA Cost Of Product Sales

Cost Of Product Sales at other companies

Falcon's Beyond GlobalFBYD

$394.75K—

Mirum Pharmaceuticals, Inc.MIRM

$28.81M+25.1%

Syndax PharmaceuticalsSNDX

$2.63M+198%

Ultragenyx PharmaceuticalRARE

$30M+3.4%

SolventumSOLV

$796M-4.7%

ArdelyxARDX

$2.88M+22.9%

Other financials

Income statement

See full

Revenue$18.3M+29.5%

Gross profit$18.0M—

Operating income-$78.8M-21.8%

Net income-$73.3M-27.7%

EPS (diluted)-$0.83-25.8%

Balance sheet

See full

Cash & equivalents$39.1M-23.8%

Total debt$24.3M+25.4%

Total equity$107.9M-70.4%

Total assets$652.6M-12.3%

Cash flow

See full

Operating cash flow-$85.9M-19.4%

CapEx$128.0K-56.2%

Free cash flow-$86.0M-19.1%

Valuation

See full

Market cap$942.78M+81.6%

Enterprise value$927.97M+90.7%

P/S13.2×+3.6×

Profitability

See full

Operating margin-443.5%+103pp

Net margin-411.2%+125pp

FCF margin130.6%+74.1pp

Returns & leverage

See full

Return on equity-124.7%-252pp

Debt / equity0.2×+0.2×

Current ratio6.1×-1.9×

Where this comes from

Reported directly by Kura Oncology in its filing.

Tagged under the XBRL concept kura:CostOfProductSales.

The official record: Kura Oncology’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kura Oncology's cost of product sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Kura Oncology's cost of product sales?: Kura Oncology (KURA) reported cost of product sales of $14.25K in Q4 2025.
What does cost of product sales mean?: This metric represents the direct costs attributable to the production and delivery of goods sold by the company during the reporting period. It encompasses raw materials, direct labor, and manufacturing overheads required to bring products to a saleable state. For a clinical-stage biopharmaceutical company, this figure reflects the scalability and efficiency of commercialized product manufacturing.